French Clinical Datbase of Melanoma Patients (RIC-Mel)

Plain-language summary

This study builds a French clinical database (RIC-Mel) that collects information from melanoma (a type of skin cancer) patients of any stage. It enrolls patients diagnosed with melanoma at any stage who agree to take part. The trial is a non-phase observational study and is currently recruiting.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

Nantes University Hospital

Start date

3/1/2012

Estimated completion

3/1/2030

Countries

France

Related genes

Locations

• Nantes, France

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Patient with melanoma, of any stage,
* Patient agreed to participate.

Exclusion Criteria:

* Individuals under court protection